Home / News
-
-
Twist Bioscience reported after the close of the market recently that revenues for its fiscal fourth quarter 2019 rose 87 percent year over year.2019-12-31View More
-
-
Cancer drug developer Oncology Pharma said recently that it has signed a letter of intent to acquire at least 50 percent of molecular genomics firm Diagnomics.2019-12-31View More
-
-
Prescient Medicine said this week that it has partnered with Dutch medical research institute Erasmus MC to evaluate its opioid addiction risk technology in a clinical study in the Netherlands.2019-12-31View More
-
-
Horizon Discovery and Mammoth Biosciences announced recently that they will collaborate to develop new CRISPR tools, with the aim of generating new engineered cell lines for the biopharmaceutical industry.2019-12-31View More
-
-
Healthcare artificial intelligence firm Tempus announced earlier this week the acquisition of Akesogen, the owner of a commercial laboratory and provider of genomics and clinical trial precision medicine services.2019-12-31View More
-
-
The National Institutes of Health has renewed funding for the Antibacterial Resistance Leadership Group (ARLG) with up to $102.5 million over seven years.2019-12-31View More
-
-
Thermo Fisher Scientific on Wednesday reported a 6 percent year-over-year increase in its third quarter revenues, driven by growth across most of its business segments.2019-12-02View More
-
-
PerkinElmer reported after the close of the market a 5 percent year-over-year increase in revenues for the third quarter, falling short of the consensus Wall Street estimate.2019-12-02View More
-
-
Illumina reported after the close of the market recently that its third quarter 2019 revenues grew 6 percent year over year.2019-12-02View More
-
-
Danaher recently reported a 4 percent year-over-year increase in its third quarter revenues, which included a 6 percent rise in life sciences segment revenues and an increase in its diagnostics segment of almost 7 percent.2019-12-02View More
-
-
Qiagen reported after the close of the market recently that its third quarter revenues increased 1 percent year over year, missing analysts' consensus estimate.2019-12-02View More
-
-
Beckman Coulter Life Sciences and IncellDx said recently that they have partnered to promote in Europe four newly developed cancer assays that incorporate technology from each company.2019-12-02View More
-
-
Roche said recently it has commenced a tender offer to purchase for cash a combined aggregate purchase price of up to $2 billion of certain notes.2019-12-02View More
-
-
Epigenetics research and sample preparation service provider Diagenode announced recently that it has partnered with Bio-Rad Laboratories to offer its single-cell transposase accessible chromatin by sequencing (ATAC-seq) services on...2019-12-02View More
-
-
Qiagen said recently that it has received several "conditional, non-binding indications of interest" from potential merger or acquisition partners.2019-12-02View More
-
-
Becton Dickinson is advising its shareholders to reject an unsolicited mini-tender offer they may have received to sell their shares of the company's stock.2019-12-02View More
-
-
Becton Dickinson said on Tuesday that it has submitted a premarket approval (PMA) supplement to the US Food and Drug Administration for an expanded version of its Onclarity human papilloma virus (HPV) assay.2019-12-02View More
-
-
Australian molecular diagnostics firm Genetic Signatures has raised $25 million, it said recently.2019-12-02View More
-
-
A consortium led by private equity firms Cinven and Astorg said recently that it has signed an agreement to acquire life science tools company LGC for an undisclosed amount, subject to regulatory approval and other customary clearances.2019-12-02View More
-
-
British life science reagents and tools company Abcam said recently that it has signed an agreement to use BrickBio's proprietary bioconjugation platform to develop research and diagnostic products.2019-12-02View More
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.